Neuberger Berman Group’s Ultragenyx Pharmaceutical RARE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,608
| Closed | -$236K | – | 2029 |
|
|
2024
Q4 | $236K | Sell |
5,608
-6
| -0.1% | -$252 | ﹤0.01% | 1740 |
|
|
2024
Q3 | $312K | Buy |
+5,614
| New | +$312K | ﹤0.01% | 1666 |
|
|
2024
Q2 | – | Sell |
-104,939
| Closed | -$4.9M | – | 1952 |
|
|
2024
Q1 | $4.9M | Buy |
104,939
+35,193
| +50% | +$1.64M | ﹤0.01% | 931 |
|
|
2023
Q4 | $3.34M | Sell |
69,746
-63,240
| -48% | -$3.02M | ﹤0.01% | 1003 |
|
|
2023
Q3 | $4.74M | Buy |
132,986
+30,341
| +30% | +$1.08M | ﹤0.01% | 890 |
|
|
2023
Q2 | $4.74M | Buy |
102,645
+33,969
| +49% | +$1.57M | ﹤0.01% | 902 |
|
|
2023
Q1 | $2.75M | Buy |
68,676
+28,890
| +73% | +$1.16M | ﹤0.01% | 1003 |
|
|
2022
Q4 | $1.84M | Buy |
+39,786
| New | +$1.84M | ﹤0.01% | 1087 |
|
|
2021
Q2 | – | Sell |
-18,585
| Closed | -$2.12M | – | 1816 |
|
|
2021
Q1 | $2.12M | Sell |
18,585
-6,042
| -25% | -$688K | ﹤0.01% | 1136 |
|
|
2020
Q4 | $3.41M | Sell |
24,627
-2,373
| -9% | -$328K | ﹤0.01% | 1005 |
|
|
2020
Q3 | $2.22M | Buy |
27,000
+7,000
| +35% | +$575K | ﹤0.01% | 1044 |
|
|
2020
Q2 | $1.56M | Sell |
20,000
-2,000
| -9% | -$156K | ﹤0.01% | 1057 |
|
|
2020
Q1 | $977K | Buy |
+22,000
| New | +$977K | ﹤0.01% | 1099 |
|